Unlike conventional respiratory viral infections, which often cause local inflammatory processes, COVID-19 can lead to systemic inflammatory responses. As noted by Doctor of Medical Sciences, a specialist in the treatment of pulmonary diseases and cardiologist Vladimir Beketov, patients with coronavirus have increased levels of C-reactive protein. He points out that, on the one hand, the virus is evolving in the direction of reducing mortality, but, on the other hand, it is no longer a completely new enemy for the immune system. The doctor emphasizes that coronavirus can cause vasculopathy.

This means inflammation of the inner layer of blood vessels. If there is a predisposition to vascular damage against the background of vasculopathy, microthrombosis can develop, which leads to disruption of the blood supply to various organs. This interferes with the normal transfer of nutrients and the elimination of toxins. Patients faced with general intoxication and microthrombosis often describe their condition as “like being run over by a truck.” With the Omicron option, blood thickening is also noted.

Features of COVID-19 include characteristic complications, such as autoimmune myocarditis, as well as an increase in the incidence of diabetes, especially among older people. It is important to remember that the mortality rate for COVID-19 is quite high compared to common respiratory viral infections.